EP1877103A4 - DENDRITIC POLYMERS WITH ENHANCED INNER FUNCTIONALITY AND AMPLIFICATION - Google Patents

DENDRITIC POLYMERS WITH ENHANCED INNER FUNCTIONALITY AND AMPLIFICATION

Info

Publication number
EP1877103A4
EP1877103A4 EP05857843A EP05857843A EP1877103A4 EP 1877103 A4 EP1877103 A4 EP 1877103A4 EP 05857843 A EP05857843 A EP 05857843A EP 05857843 A EP05857843 A EP 05857843A EP 1877103 A4 EP1877103 A4 EP 1877103A4
Authority
EP
European Patent Office
Prior art keywords
amplification
dendritic polymers
enhanced inner
functionality
inner functionality
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05857843A
Other languages
German (de)
French (fr)
Other versions
EP1877103A2 (en
Inventor
Donald A Tomalia
Douglas R Swanson
Baohua Huang
Verra Reddy Pulgam
Joseph R Heinzelmann
Sonke Svenson
Lori A Reyna
Michael A Zhuravel
Abhay Singh Chauhan
Cordell R Demattel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dendritic Nanotechnologies Inc
Original Assignee
Dendritic Nanotechnologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2005/013864 external-priority patent/WO2006065266A2/en
Application filed by Dendritic Nanotechnologies Inc filed Critical Dendritic Nanotechnologies Inc
Priority to EP10184062A priority Critical patent/EP2325236A1/en
Publication of EP1877103A2 publication Critical patent/EP1877103A2/en
Publication of EP1877103A4 publication Critical patent/EP1877103A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/593Polyesters, e.g. PLGA or polylactide-co-glycolide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/595Polyamides, e.g. nylon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/0002General or multifunctional contrast agents, e.g. chelated agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y10/00Nanotechnology for information processing, storage or transmission, e.g. quantum computing or single electron logic
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G83/00Macromolecular compounds not provided for in groups C08G2/00 - C08G81/00
    • C08G83/002Dendritic macromolecules
    • C08G83/003Dendrimers
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L101/00Compositions of unspecified macromolecular compounds
    • C08L101/005Dendritic macromolecules
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09BORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B67/00Influencing the physical, e.g. the dyeing or printing properties of dyestuffs without chemical reactions, e.g. by treating with solvents grinding or grinding assistants, coating of pigments or dyes; Process features in the making of dyestuff preparations; Dyestuff preparations of a special physical nature, e.g. tablets, films
    • C09B67/0001Post-treatment of organic pigments or dyes
    • C09B67/0004Coated particulate pigments or dyes
    • C09B67/0008Coated particulate pigments or dyes with organic coatings
    • C09B67/0013Coated particulate pigments or dyes with organic coatings with polymeric coatings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nanotechnology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Polymers & Plastics (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Rheumatology (AREA)
  • Medical Informatics (AREA)
  • Mathematical Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Polyethers (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EP05857843A 2005-04-20 2005-12-21 DENDRITIC POLYMERS WITH ENHANCED INNER FUNCTIONALITY AND AMPLIFICATION Withdrawn EP1877103A4 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP10184062A EP2325236A1 (en) 2005-04-20 2005-12-21 Dendritic polymers with enhanced amplification and interior functionality

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US2005/013864 WO2006065266A2 (en) 2004-04-20 2005-04-20 Dendritic polymers with enhanced amplification and interior functionality
PCT/US2005/047635 WO2006115547A2 (en) 2005-04-20 2005-12-21 Dendritic polymers with enhanced amplification and interior functionality

Publications (2)

Publication Number Publication Date
EP1877103A2 EP1877103A2 (en) 2008-01-16
EP1877103A4 true EP1877103A4 (en) 2010-11-03

Family

ID=37215167

Family Applications (2)

Application Number Title Priority Date Filing Date
EP05857843A Withdrawn EP1877103A4 (en) 2005-04-20 2005-12-21 DENDRITIC POLYMERS WITH ENHANCED INNER FUNCTIONALITY AND AMPLIFICATION
EP10184062A Withdrawn EP2325236A1 (en) 2005-04-20 2005-12-21 Dendritic polymers with enhanced amplification and interior functionality

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP10184062A Withdrawn EP2325236A1 (en) 2005-04-20 2005-12-21 Dendritic polymers with enhanced amplification and interior functionality

Country Status (6)

Country Link
EP (2) EP1877103A4 (en)
JP (1) JP2008545621A (en)
CA (1) CA2598430C (en)
MX (1) MX2007010402A (en)
TW (1) TWI356709B (en)
WO (1) WO2006115547A2 (en)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0510093B8 (en) * 2004-04-20 2022-12-27 Dendritic Nanotechnologies Inc dendritic polymers
US20090012033A1 (en) * 2006-03-03 2009-01-08 Demattei Cordell R Delivery of Biologically Active Materials Using Core-Shell Tecto(Dendritic Polymers)
DE102006036326A1 (en) * 2006-08-03 2008-02-07 Charité - Universitätsmedizin Berlin Dendritic polyglycerol sulfates and sulfonates and their use in inflammatory diseases
WO2008030591A2 (en) * 2006-09-08 2008-03-13 Dendritic Nanotechnologies, Inc. Peham dendrimers as excipients
US7939095B2 (en) * 2006-12-21 2011-05-10 Cordis Corporation Crosslinked silane coating for medical devices
EP1958624A1 (en) * 2007-02-16 2008-08-20 Freie Universität Berlin Divalent metal-ion loaded nano-transport system having a dendritic architecture useful for therapy
FR2925505B1 (en) * 2007-12-24 2010-04-02 Arkema France PROCESS FOR THE PREPARATION OF A MATERIAL FORMED OF ARBORESCENT MOLECULES COMPRISING ASSOCIATIVE GROUPS
US8071679B2 (en) * 2008-02-29 2011-12-06 Ppg Industries Ohio, Inc Coating compositions comprising a polymer containing an oligomeric macromonomer
JP5093680B2 (en) * 2008-06-26 2012-12-12 独立行政法人産業技術総合研究所 Bisquaternary ammonium salt core type dendrimer
FR2935836B1 (en) * 2008-09-08 2012-11-23 Commissariat Energie Atomique SEMICONDUCTOR NANOCRYSTALS
GB0901857D0 (en) * 2009-02-05 2009-03-11 Nanoco Technologies Ltd Encapsulated nanoparticles
IT1393368B1 (en) * 2009-03-23 2012-04-20 Dipharma Francis Srl METHOD FOR THE PREPARATION OF RUFINAMIDE
EP2417262B1 (en) * 2009-04-07 2015-05-20 Dow AgroSciences LLC Nanoparticle mediated delivery of sequence specific nucleases
JP2011055751A (en) * 2009-09-09 2011-03-24 Tokyo Univ Of Agriculture & Technology Method for preparing dendrimer-modified magnetic fine particle
US8247151B2 (en) 2009-10-19 2012-08-21 Hewlett-Packard Development Company, L.P. Liquid toner, electrophoretic ink, and methods of making and use
WO2011053605A1 (en) * 2009-10-26 2011-05-05 Dendritic Nanotechnologies, Inc. Peham dendrimers for use in agriculture
CN102712761B (en) * 2009-12-21 2014-09-24 帝斯曼知识产权资产管理有限公司 Polymer, process and composition
CN103037903A (en) 2010-05-18 2013-04-10 天蓝制药公司 Compositions and methods for treating autoimmune or other diseases
FR2961208B1 (en) * 2010-06-09 2012-11-23 Oreal POLY 2-PYRROLIDONES FUNCTIONALIZED BY A RADICAL ESTER, ACID OR AMIDE, COSMETIC COMPOSITION COMPRISING SAME AND THEIR USE AS A DISPERSING AGENT
AU2011291582A1 (en) * 2010-08-20 2013-03-07 Cerulean Pharma Inc. Conjugates, particles, compositions, and related methods
IT1402520B1 (en) * 2010-10-19 2013-09-13 Ivm Chemicals Srl NON-HARMFUL COATING ACTIVE AGAINST MICRO-ORGANISMS
WO2012094620A2 (en) * 2011-01-09 2012-07-12 Anp Technologies, Inc. Hydrophobic molecule-induced branched polymer aggregates and their use
US9334351B2 (en) 2011-06-17 2016-05-10 Isp Investments Inc. 4- and 5-substituted 1,2,3-triazole, and regioisomer mixtures thereof, modified polymers
US20140228484A1 (en) * 2011-06-21 2014-08-14 Dsm Ip Asset B.V. Polymer, process and use
US20140200333A1 (en) * 2011-08-15 2014-07-17 Seta Biomedicals, Llc Dendron reporter molecules
WO2013087789A1 (en) 2011-12-13 2013-06-20 Glykos Finland Ltd. Antibody isoform arrays and methods thereof
JP5920024B2 (en) * 2012-05-25 2016-05-18 Dic株式会社 Method for producing sulfonylamide compound containing fluorinated aliphatic group and method for producing anionic hydrophilic group-containing surfactant
WO2013188789A2 (en) 2012-06-14 2013-12-19 Whitehead Institute For Biomedical Research Genome-wide method of assessing interactions between chemical entities and their target molecules
TWI524825B (en) 2012-10-29 2016-03-01 財團法人工業技術研究院 Method of transferring carbon conductive film
WO2014136906A1 (en) * 2013-03-06 2014-09-12 Jx日鉱日石エネルギー株式会社 Friction modifier and lubricating-oil composition
US20160303242A1 (en) * 2013-12-09 2016-10-20 Durect Corporation Pharmaceutically Active Agent Complexes, Polymer Complexes, and Compositions and Methods Involving the Same
DK3145984T3 (en) 2014-05-21 2022-04-11 Icd Therapeutics Gmbh THERAPEUTIC CONJUGATES WITH SULFATED DENDRIMERS FOR INTRACELLULAR TARGETING
EP3148553A4 (en) 2014-05-29 2017-11-29 The University Of British Columbia Antithrombotic compounds, methods and uses thereof
WO2016025741A1 (en) 2014-08-13 2016-02-18 The Johns Hopkins University Selective dendrimer delivery to brain tumors
US10968176B2 (en) 2014-09-14 2021-04-06 Nanosynthons Llc Pyrrolidone derivatives, oligomers and polymers
WO2016040962A1 (en) * 2014-09-14 2016-03-17 Nanosynthons Llc Pyrrolidone derivatives, oligomers and polymers
WO2016046847A1 (en) 2014-09-23 2016-03-31 Council Of Scientific & Industrial Research Metal embedded hydrophilic polymer for drug delivery applications
TWI557154B (en) * 2015-07-02 2016-11-11 國立臺灣科技大學 Supramolecular polymer and method for making same
CN104928919B (en) * 2015-07-10 2017-03-08 广州大学 A kind of softness Synergistic antimicrobial brush-type multi-quaternary ammonium salt fabric finishing agent and preparation method thereof
CA3008648C (en) 2015-12-16 2023-01-10 Priostar Pty Ltd Dendrimer and formulations thereof
WO2018201007A2 (en) 2017-04-27 2018-11-01 The Johns Hopkins University Dendrimer compositions for use in angiography
CA3082121C (en) 2017-11-10 2023-01-24 The Johns Hopkins University Dendrimer delivery system and methods of use thereof
PL3827042T3 (en) 2018-07-23 2024-08-12 Covestro (Netherlands) B.V. Multi-aziridine compound
US10954346B2 (en) 2018-12-27 2021-03-23 Industrial Technology Research Institute Resin and ink
CN113518757A (en) * 2019-03-13 2021-10-19 伊士曼化工公司 Processes that can be used to manufacture cyclododecylsulfide
CN110694599A (en) * 2019-09-26 2020-01-17 浙江海洋大学 A kind of preparation method of polypropyleneimine modified magnetic nanocrystalline cellulose molecularly imprinted polymer
JP7759322B2 (en) 2019-12-04 2025-10-23 アシュバッタ セラピューティクス, インコーポレイテッド Dendrimer compositions and methods for ocular drug delivery
EP4093799A1 (en) 2020-01-22 2022-11-30 Covestro (Netherlands) B.V. Aziridine functional compound
CN111440824B (en) * 2020-05-26 2022-07-12 北京化工大学 Liver-targeted cationic gene vector constructed based on lactose through amino-epoxy ring-opening reaction and preparation method thereof
CN111848969A (en) * 2020-07-27 2020-10-30 洛阳理工学院 A kind of hyperbranched bifunctional star compound, polymer electrolyte material and preparation and application
CN113698549B (en) * 2021-09-03 2024-05-14 上海昶法新材料有限公司 Hyperbranched polymer, preparation method, application and washing product thereof
CN116023669B (en) * 2021-10-27 2023-12-15 兰州大学 A hybrid arm supramolecular star copolymer, its preparation method and application
CN114044907B (en) * 2021-12-15 2022-11-11 兴宇汽车零部件股份有限公司 Intumescent flame retardant functionalized POSS flame retardant and preparation method thereof
CN114606190B (en) * 2022-03-08 2024-09-17 东南大学 Nanometer reagent for cell killing and bubble generation, cell micrometer vesicle, and preparation method and application thereof
CN114632194B (en) * 2022-04-11 2023-05-23 东莞市人民医院 Coating material with long-acting NO catalytic release and preparation method and application thereof
CN115044008B (en) * 2022-06-01 2024-01-05 武汉中科先进材料科技有限公司 Hydrophilic cationic photo-curing resin and preparation method and application thereof
CN115057552B (en) * 2022-06-23 2023-06-02 先导薄膜材料有限公司 Concentration method of low-concentration ammonium nitrate wastewater
CN115678271B (en) * 2022-11-02 2023-08-22 常州大学 Preparation method of bio-based polyamide plant dye masterbatch
CN116120575B (en) * 2023-01-09 2024-06-21 汕头大学 A silicon dioxide grafted polymer and its preparation method and application
WO2024260311A1 (en) * 2023-06-19 2024-12-26 华南理工大学 Ph-sensitive membrane lysis material based on sequence-immobilized polylysine, and use thereof
KR20260043131A (en) * 2023-07-26 2026-03-31 토모이케 바이오 리미티드 A branched multi-hydroxyl group protected oligomer, a linker formed by combining the same, and a branched multi-hydroxyl group oligomer formed by deprotecting the linker
CN117946349B (en) * 2024-03-26 2024-07-09 潍坊弘润新材料有限公司 Dendritic polymer modified hydroxyl acrylic emulsion, preparation method and application
CN120398432B (en) * 2024-12-02 2025-12-02 江苏辛巴新材料科技股份有限公司 A method for preparing hydrophobic and oleophobic photovoltaic glass
CN119735820B (en) * 2024-12-25 2025-06-24 杭州师范大学 Selenium-containing hyperbranched polymer and preparation method and application thereof
CN120230334B (en) * 2025-04-27 2025-11-04 淮安新坤安防科技有限公司 Wear-resistant butyronitrile composite material and preparation method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0271180A1 (en) * 1986-08-18 1988-06-15 The Dow Chemical Company Starburst conjugates
US5773527A (en) * 1990-08-27 1998-06-30 Dendritech, Inc. Non-crosslinked, polybranched polymers
WO2006065266A2 (en) * 2004-04-20 2006-06-22 Dendritic Nanotechnologies, Inc. Dendritic polymers with enhanced amplification and interior functionality

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4361337A (en) 1979-05-15 1982-11-30 Adriel Montes Piston ring with tongue and groove joint
US4631337A (en) 1983-01-07 1986-12-23 The Dow Chemical Company Hydrolytically-stable dense star polyamine
US4558120A (en) 1983-01-07 1985-12-10 The Dow Chemical Company Dense star polymer
US4507466A (en) 1983-01-07 1985-03-26 The Dow Chemical Corporation Dense star polymers having core, core branches, terminal groups
US4737550A (en) 1983-01-07 1988-04-12 The Dow Chemical Company Bridged dense star polymers
US4568737A (en) 1983-01-07 1986-02-04 The Dow Chemical Company Dense star polymers and dendrimers
IL69558A (en) 1983-08-23 1988-06-30 Yeda Res & Dev Synthetic cholera vaccine
US4695624A (en) 1984-05-10 1987-09-22 Merck & Co., Inc. Covalently-modified polyanionic bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency
US4740585A (en) 1984-07-30 1988-04-26 The Board Of Trustees Of The Leland Stanford Junior University Synthetic vaccine against urinary infections
US4587329A (en) 1984-08-17 1986-05-06 The Dow Chemical Company Dense star polymers having two dimensional molecular diameter
US4599400A (en) 1984-12-18 1986-07-08 The Dow Chemical Company Star/comb-branched polyamide
US5338532A (en) 1986-08-18 1994-08-16 The Dow Chemical Company Starburst conjugates
US4735799A (en) 1987-01-14 1988-04-05 Patarroyo Manuel E Malaria vaccine
US5631329A (en) 1990-08-27 1997-05-20 Dendritech, Inc. Process for producing hyper-comb-branched polymers
ATE277640T1 (en) 1994-03-07 2004-10-15 Dow Chemical Co BIOACTIVE AND/OR TARGETED DENDRIMERE CONJUGATES CONTAINING GENETIC MATERIAL
SE503342C2 (en) * 1994-10-24 1996-05-28 Perstorp Ab Polyester-type hyperbranched macromolecule and process for its preparation
IT1277596B1 (en) * 1995-09-15 1997-11-11 Bracco Spa MACROMOLECULAR COMPOUNDS OF THE DENDRIMERIC TYPE
US5760142A (en) * 1996-12-04 1998-06-02 Dentsply Detrey G.M.B.H. Epoxide-amine dendrimers and the preparation and use thereof
FR2790642A1 (en) * 1999-03-08 2000-09-15 Aventis Cropscience Sa NEW PESTICIDE AND / OR REGULATORY GROWTH COMPOSITIONS
GB0125216D0 (en) * 2001-10-19 2001-12-12 Univ Strathclyde Dendrimers for use in targeted delivery
NO322724B1 (en) * 2004-04-15 2006-12-04 Sinvent As Process for preparing polybranched organic / inorganic hybrid polymer

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0271180A1 (en) * 1986-08-18 1988-06-15 The Dow Chemical Company Starburst conjugates
US5773527A (en) * 1990-08-27 1998-06-30 Dendritech, Inc. Non-crosslinked, polybranched polymers
WO2006065266A2 (en) * 2004-04-20 2006-06-22 Dendritic Nanotechnologies, Inc. Dendritic polymers with enhanced amplification and interior functionality

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
TANG L-M ET AL: "Structure, solution aggregation and UV curing of hyperbranched poly(ester-amine)s with terminal acrylate groups", POLYMER JOURNAL, SOCIETY OF POLYMER SCIENCE, TOKYO, JP LNKD- DOI:10.1295/POLYMJ.37.255, vol. 37, no. 4, 15 April 2005 (2005-04-15), pages 255 - 261, XP002567947, ISSN: 0032-3896 *
XU D ET AL: "Fast growing dendritic poly(ester-amines) from alternate reaction of EDA and TMPTA", TETRAHEDRON LETTERS, ELSEVIER, AMSTERDAM, NL LNKD- DOI:10.1016/J.TETLET.2005.01.180, vol. 46, no. 14, 4 April 2005 (2005-04-04), pages 2503 - 2505, XP004785784, ISSN: 0040-4039 *

Also Published As

Publication number Publication date
CA2598430A1 (en) 2006-11-02
JP2008545621A (en) 2008-12-18
EP2325236A1 (en) 2011-05-25
TWI356709B (en) 2012-01-21
CA2598430C (en) 2011-10-25
WO2006115547A3 (en) 2009-06-04
EP1877103A2 (en) 2008-01-16
WO2006115547A8 (en) 2007-02-15
MX2007010402A (en) 2008-01-22
TW200801075A (en) 2008-01-01
WO2006115547A2 (en) 2006-11-02

Similar Documents

Publication Publication Date Title
EP1737899A4 (en) DENDRITIC POLYMERS WITH IMPROVED AMPLIFICATION AND INNER FUNCTIONALITY
EP2032652A4 (en) RETICULATED AND DEGRADABLE POLYMERS AND USES THEREOF
DE502006009127D1 (en) PLASTIC METAL CONNECTION
DE602006015258D1 (en) Pick-up and round baler
DE602006008371D1 (en) Connection detection connector and connection detection connector assembly
EP1782313A4 (en) APPLICATIONS WITH INTEGRATED CAPTURE
DE602005021959D1 (en) SUBSTITUTED DIAZASPIROÄ4.5ÜDECANDERIVATE AND DER
EP1841307A4 (en) IMPROVED TELESCOPIC DIFFUSER
EP1684388A4 (en) CASE PROVIDED WITH CONNECTOR
DE602005003890D1 (en) Connector and connector assembly
DE602006012525D1 (en) POLYMER GRAFT
NL1032915A1 (en) Catheter point.
DE602005020384D1 (en) Connector and assembly
ITMO20050167A1 (en) EQUIPMENT AND METHODS.
DE602006001781D1 (en) Connector and connector assembly
EP1619792A4 (en) PR AMPLIFIER
DE602006016225D1 (en) Connector and connector assembly
DK1815144T3 (en) Impeller
DE602006004152D1 (en) Connector and connector assembly
DE602006001091D1 (en) Connector and connector assembly
BRPI0613947A2 (en) set and tire
FR2903744B1 (en) NUT MOLD SECURE AND MOLDED PIECE WITH SUCH NUT.
IL179510A0 (en) Dendritic polymers with enhanced amplification and interior functionality
EP1890932A4 (en) IMPROVED EJECTOR
FR2912170B1 (en) ISOLOIR DEMONTABLE AND MODULABLE.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20071120

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK YU

RIN1 Information on inventor provided before grant (corrected)

Inventor name: DEMATTEL, CORDELL, R.

Inventor name: HUANG, BAOHUA

Inventor name: TOMALIA, DONALD, A.

Inventor name: ZHURAVEL, MICHAEL, A.

Inventor name: SWANSON, DOUGLAS, R.

Inventor name: PULGAM, VERRA, REDDY

Inventor name: REYNA, LORI, A.

Inventor name: HEINZELMANN, JOSEPH, R.

Inventor name: SVENSON, SONKE

Inventor name: CHAUHAN, ABHAY, SINGH

DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1116678

Country of ref document: HK

R17D Deferred search report published (corrected)

Effective date: 20090604

RIC1 Information provided on ipc code assigned before grant

Ipc: C08K 9/00 20060101ALI20090611BHEP

Ipc: C08J 3/00 20060101AFI20090611BHEP

Ipc: C08J 9/32 20060101ALI20090611BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20101006

RIC1 Information provided on ipc code assigned before grant

Ipc: C08G 83/00 20060101AFI20100930BHEP

Ipc: A61K 47/48 20060101ALI20100930BHEP

Ipc: A61K 49/00 20060101ALI20100930BHEP

Ipc: A61K 48/00 20060101ALN20100930BHEP

17Q First examination report despatched

Effective date: 20110901

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1116678

Country of ref document: HK

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20180703